Rydberg MG.
Reply to "Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US".
Alzheimers Dement. 2025 Feb;21(2):e14620.
PubMed.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.